Basilea Pharmaceutica AG/€BSLN
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Basilea Pharmaceutica AG
Ticker
€BSLN
Sector
Primary listing
XSWX
Industry
Biotechnology
Headquarters
Allschwil, Switzerland
Employees
164
Website
BSLN Metrics
BasicAdvanced
€765M
9.93
€6.27
0.73
-
Price and volume
Market cap
€765M
Beta
0.73
52-week high
€63.10
52-week low
€39.27
Average daily volume
36K
Financial strength
Current ratio
4.849
Quick ratio
3.927
Long term debt to equity
135.321
Total debt to equity
137.867
Interest coverage (TTM)
14.20%
Profitability
EBITDA (TTM)
67.371
Gross margin (TTM)
44.46%
Net profit margin (TTM)
37.21%
Operating margin (TTM)
29.59%
Effective tax rate (TTM)
-28.76%
Revenue per employee (TTM)
€1,366,100
Management effectiveness
Return on assets (TTM)
17.89%
Return on equity (TTM)
218.60%
Valuation
Price to earnings (TTM)
9.934
Price to revenue (TTM)
3.358
Price to book
8.68
Price to tangible book (TTM)
8.72
Price to free cash flow (TTM)
9.649
Free cash flow yield (TTM)
10.36%
Free cash flow per share (TTM)
6.457
Growth
Revenue change (TTM)
32.27%
Earnings per share change (TTM)
577.28%
3-year revenue growth (CAGR)
12.08%
10-year revenue growth (CAGR)
17.24%
3-year earnings per share growth (CAGR)
115.23%
10-year earnings per share growth (CAGR)
3.40%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Basilea Pharmaceutica AG stock?
Basilea Pharmaceutica AG (BSLN) has a market cap of €765M as of August 01, 2025.
What is the P/E ratio for Basilea Pharmaceutica AG stock?
The price to earnings (P/E) ratio for Basilea Pharmaceutica AG (BSLN) stock is 9.93 as of August 01, 2025.
Does Basilea Pharmaceutica AG stock pay dividends?
No, Basilea Pharmaceutica AG (BSLN) stock does not pay dividends to its shareholders as of August 01, 2025.
When is the next Basilea Pharmaceutica AG dividend payment date?
Basilea Pharmaceutica AG (BSLN) stock does not pay dividends to its shareholders.
What is the beta indicator for Basilea Pharmaceutica AG?
Basilea Pharmaceutica AG (BSLN) has a beta rating of 0.73. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.